Induced Pluripotent Stem Cell Differentiation Enables Functional Validation of 
GWAS Variants in Metabolic Disease

Warren, Curtis R.; O’Sullivan, John F.; Friesen, Max; Becker, Caroline E.; Zhang, Xiaoling; Liu, Poching; Wakabayashi, Yoshiyuki; Morningstar, Jordan E.; Shi, Xu; Choi, Jihoon; Xia, Fang; Peters, Derek T.; Florido, Mary H. C.; Tsankov, Alexander M.; Duberow, Eilene; Comisar, Lauren; Shay, Jennifer; Jiang, Xin; Meissner, Alexander; Musunuro, Kiran; Kathiresan, Sekar; Daheron, Laurence; Zhu, Jun; Gerszten, Robert E.; Deo, Rahul C.; Vasan, Ramachandran S.; O’Donnell, Christopher J.; Cowan, Chad A.

doi:10.1016/j.stem.2017.01.010

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Induced Pluripotent Stem Cell Differentiation Enables Functional Validation of GWAS Variants in Metabolic Disease

MPS-Authors

/persons/resource/persons203770

Meissner, Alexander
Dept. of Genome Regulation (Head: Alexander Meissner), Max Planck Institute for Molecular Genetics, Max Planck Society;
Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

Warren.pdf
(Publisher version), 3MB

Supplementary Material (public)

There is no public supplementary material available

Citation

Warren, C. R., O’Sullivan, J. F., Friesen, M., Becker, C. E., Zhang, X., Liu, P., et al. (2017). Induced Pluripotent Stem Cell Differentiation Enables Functional Validation of GWAS Variants in Metabolic Disease. Cell Stem Cell, 20(4), 547-557. doi:10.1016/j.stem.2017.01.010.

Cite as: https://hdl.handle.net/11858/00-001M-0000-002D-DCED-9

Abstract

Genome-wide association studies (GWAS) have highlighted a large number of genetic variants with potential disease association, but functional analysis remains a challenge. Here we describe an approach to functionally validate identified variants through differentiation of induced pluripotent stem cells (iPSCs) to study cellular pathophysiology. We collected peripheral blood cells from Framingham Heart Study participants and reprogrammed them to iPSCs. We then differentiated 68 iPSC lines into hepatocytes and adipocytes to investigate the effect of the 1p13 rs12740374 variant on cardiometabolic disease phenotypes via transcriptomics and metabolomic signatures. We observed a clear association between rs12740374 and lipid accumulation and gene expression in differentiated hepatocytes, in particular, expression of SORT1, CELSR2, and PSRC1, consistent with previous analyses of this variant using other approaches. Initial investigation of additional SNPs also highlighted correlations with gene expression. These findings suggest that iPSC-based population studies hold promise as tools for the functional validation of GWAS variants.